Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Daewoong Therapeutics is developing a microneedle semaglutide patch that achieved over 80% bioavailability in a Phase 1 study with 70 healthy volunteers
It frames the improvements it reports as reflecting reduced inflammation and restored hepatic metabolic function, rather than reversal of underlying liver disease
Dosage, delivery method (oral, subcutaneous, or transdermal), and treatment duration should be tailored to each individuals needs and health history
These statements have not been evaluated by the FDA [or your local regulator]
US$ 27.65
US$ 24.33
US$ 23.27
US$ 22.45
US$ 26.06
US$ 29.21
US$ 24.08
US$ 24.91
US$ 29.17
US$ 26.87
